Sabby Management’s Cel-Sci Corp Series S CVM.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-1,916
Closed -$1.66M – 218
2021
Q2
$1.66M Buy
1,916
+468
+32% +$406K 0.23% 66
2021
Q1
$2.2M Sell
1,448
-4,055
-74% -$6.17M 0.43% 47
2020
Q4
$6.42M Sell
5,503
-2,270
-29% -$2.65M 1.23% 16
2020
Q3
$9.91M Buy
7,773
+4,689
+152% +$5.98M 1.48% 14
2020
Q2
$4.6M Buy
3,084
+832
+37% +$1.24M 0.92% 21
2020
Q1
$2.6M Buy
+2,252
New +$2.6M 1.08% 13
2019
Q4
– Sell
-855
Closed -$764K – 106
2019
Q3
$764K Sell
855
-537
-39% -$480K 0.41% 28
2019
Q2
$703K Buy
1,392
+1,080
+346% +$545K 0.88% 24
2019
Q1
$110K Buy
312
+202
+184% +$71.2K 0.05% 58
2018
Q4
$32K Buy
+110
New – 0.01% 102

Sabby Management's CVM.WS Position: Q3 2015 in Review

Sabby Management sold out of Cel-Sci Corp Series S (CVM.WS) in Q3 2015, closing a stake of 1,845,841 shares — an estimated $369K sold.

Sabby Management first reported a position in CVM.WS in Q1 2014 and held it in 6 quarters. The position peaked at $2.68M in Q1 2014. 7 funds tracked by Wall St. Rank hold CVM.WS as of Q3 2015.

  • Sabby Management reported no remaining Cel-Sci Corp Series S position as of Q3 2015 after selling out during the quarter.
  • Sabby Management sold 1,845,841 Cel-Sci Corp Series S shares in Q3 2015, an estimated $369K.
  • Sabby Management first reported a position in Cel-Sci Corp Series S in Q1 2014 and held it in 6 quarters.
  • Sabby Management's Cel-Sci Corp Series S position peaked at $2.68M in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Cel-Sci Corp Series S as of Q3 2015.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.